scispace - formally typeset
C

Claude Laberge

Researcher at Laval University

Publications -  71
Citations -  2419

Claude Laberge is an academic researcher from Laval University. The author has contributed to research in topics: Population & Mass screening. The author has an hindex of 26, co-authored 71 publications receiving 2336 citations. Previous affiliations of Claude Laberge include McGill University.

Papers
More filters
Journal ArticleDOI

Preliminary report on a mass screening program for neonatal hypothyroidism.

TL;DR: The frequency of congenital hypothyroidism is about one in 7,000 births and the immunoassay is effective in detecting thyroid hormone abnormalities with an acceptable percentage of false positive measurements; no false negative results have occurred.
Journal ArticleDOI

Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24.

TL;DR: A genome-wide scan for susceptibility loci for bipolar affective disorders in families derived from a rather homogeneous population in the Province of Québec found presumed linkages found in the region of chromosome 12q23-q24.
Journal ArticleDOI

Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics

TL;DR: The CaG study is one of the few population-based cohorts in the world where blood is stored not only for DNA and protein based science but also for gene expression analyses, opening the door for multiple systems genomics approaches that identify genetic and environmental factors associated with disease-related quantitative traits.
Journal ArticleDOI

Community Engagement in Genetic Research: Results of the First Public Consultation for the Quebec CARTaGENE Project

TL;DR: The first public consultation for the creation of a large-scale genetic database, the Quebec CARTaGENE project, is presented in order to gauge whether the general public is receptive to the project.
Journal Article

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).

TL;DR: It is confirmed that the primary defect in the acute form of hereditary tyrosinemia is an absence of FAH, and the data suggest that both clinical forms of the disease have a different molecular basis.